REPORT ID 6270

EMEA (Europe, Middle East and Africa) Secondary Antibodies Market Report 2019

Publish Date
2019
Pages
120
Format
Electronic (PDF)

In this report, the EMEA Secondary Antibodies market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Secondary Antibodies for these regions, from   2019 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Secondary Antibodies market competition by top manufacturers/players, with Secondary Antibodies sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Thermo Fisher Scientific (US)
    Jackson ImmunoResearch Laboratories (US)
    BD Biosciences (US)
    Santa Cruz Biotechnology (US)
    GE Healthcare (US)
    Sigma-Aldrich (US)
    Dako (US)
    LI-COR Biosciences (US)
    SouthernBiotech (US)
    Vector Laboratories (US)
    Bio-Rad (US)
    eBioscience (US)
    Cell Signaling Technology (US)
    Dianova (Germany)
    Abcam (UK)
    EMD Millipore (US)
    R&D Systems (US)
    Rockland Immunochemicals (US)
    Bethyl (US)
    Kirkegaard & Perry Laboratories (US)
    BioLegend (US)
    Abbexa (UK)
    Biorbyt (UK)
    Acris Antibodies (Germany)
    BioLogo (Germany)
    Sino Biological (China)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Men'
    Animals'

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    ELISA (Including Many HIV Tests)
    Western Blot
    Immunostaining
    Immunohistochemistry
    Immunocytochemistry

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Secondary Antibodies Market  Report 2019
1 Secondary Antibodies Overview
    1.1 Product Overview and Scope of Secondary Antibodies
    1.2 Classification of Secondary Antibodies
        1.2.1 EMEA Secondary Antibodies Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 EMEA Secondary Antibodies Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Men'
        1.2.4 Animals'
    1.3 EMEA Secondary Antibodies Market by Application/End Users
        1.3.1 EMEA Secondary Antibodies Sales (Volume) and Market Share Comparison by Application ( 2014-2024
        1.3.2 ELISA (Including Many HIV Tests)
        1.3.3 Western Blot
        1.3.4 Immunostaining
        1.3.5 Immunohistochemistry
        1.3.6 Immunocytochemistry
    1.4 EMEA Secondary Antibodies Market by Region
        1.4.1 EMEA Secondary Antibodies Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 Europe Status and Prospect ( 2014-2024)
        1.4.3 Middle East Status and Prospect ( 2014-2024)
        1.4.4 Africa Status and Prospect ( 2014-2024)
    1.5 EMEA Market Size (Value and Volume) of Secondary Antibodies ( 2014-2024)
        1.5.1 EMEA Secondary Antibodies Sales and Growth Rate ( 2014-2024)
        1.5.2 EMEA Secondary Antibodies Revenue and Growth Rate ( 2014-2024)

2 EMEA Secondary Antibodies Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Secondary Antibodies Market Competition by Players/Manufacturers
        2.1.1 EMEA Secondary Antibodies Sales Volume and Market Share of Major Players ( 2014-2019)
        2.1.2 EMEA Secondary Antibodies Revenue and Share by Players ( 2014-2019)
        2.1.3 EMEA Secondary Antibodies Sale Price by Players ( 2014-2019)
    2.2 EMEA Secondary Antibodies (Volume and Value) by Type/Product Category
        2.2.1 EMEA Secondary Antibodies Sales and Market Share by Type ( 2014-2019)
        2.2.2 EMEA Secondary Antibodies Revenue and Market Share by Type ( 2014-2019)
        2.2.3 EMEA Secondary Antibodies Sale Price by Type ( 2014-2019)
    2.3 EMEA Secondary Antibodies (Volume) by Application
    2.4 EMEA Secondary Antibodies (Volume and Value) by Region
        2.4.1 EMEA Secondary Antibodies Sales and Market Share by Region ( 2014-2019)
        2.4.2 EMEA Secondary Antibodies Revenue and Market Share by Region ( 2014-2019)
        2.4.3 EMEA Secondary Antibodies Sales Price by Region ( 2014-2019)

3 Europe Secondary Antibodies (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Secondary Antibodies Sales and Value ( 2014-2019)
        3.1.1 Europe Secondary Antibodies Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 Europe Secondary Antibodies Revenue and Growth Rate ( 2014-2019)
    3.2 Europe Secondary Antibodies Sales and Market Share by Type
    3.3 Europe Secondary Antibodies Sales and Market Share by Application
    3.4 Europe Secondary Antibodies Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Secondary Antibodies Sales Volume by Countries ( 2014-2019)
        3.4.2 Europe Secondary Antibodies Revenue by Countries ( 2014-2019)
        3.4.3 Germany Secondary Antibodies Sales and Growth Rate ( 2014-2019)
        3.4.4 France Secondary Antibodies Sales and Growth Rate ( 2014-2019)
        3.4.5 UK Secondary Antibodies Sales and Growth Rate ( 2014-2019)
        3.4.6 Russia Secondary Antibodies Sales and Growth Rate ( 2014-2019)
        3.4.7 Italy Secondary Antibodies Sales and Growth Rate ( 2014-2019)
        3.4.8 Benelux Secondary Antibodies Sales and Growth Rate ( 2014-2019)

4 Middle East Secondary Antibodies (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Secondary Antibodies Sales and Value ( 2014-2019)
        4.1.1 Middle East Secondary Antibodies Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Middle East Secondary Antibodies Revenue and Growth Rate ( 2014-2019)
    4.2 Middle East Secondary Antibodies Sales and Market Share by Type
    4.3 Middle East Secondary Antibodies Sales and Market Share by Application
    4.4 Middle East Secondary Antibodies Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Secondary Antibodies Sales Volume by Countries ( 2014-2019)
        4.4.2 Middle East Secondary Antibodies Revenue by Countries ( 2014-2019)
        4.4.3 Saudi Arabia Secondary Antibodies Sales and Growth Rate ( 2014-2019)
        4.4.4 Israel Secondary Antibodies Sales and Growth Rate ( 2014-2019)
        4.4.5 UAE Secondary Antibodies Sales and Growth Rate ( 2014-2019)
        4.4.6 Iran Secondary Antibodies Sales and Growth Rate ( 2014-2019)

5 Africa Secondary Antibodies (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Secondary Antibodies Sales and Value ( 2014-2019)
        5.1.1 Africa Secondary Antibodies Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 Africa Secondary Antibodies Revenue and Growth Rate ( 2014-2019)
    5.2 Africa Secondary Antibodies Sales and Market Share by Type
    5.3 Africa Secondary Antibodies Sales and Market Share by Application
    5.4 Africa Secondary Antibodies Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Secondary Antibodies Sales Volume by Countries ( 2014-2019)
        5.4.2 Africa Secondary Antibodies Revenue by Countries ( 2014-2019)
        5.4.3 South Africa Secondary Antibodies Sales and Growth Rate ( 2014-2019)
        5.4.4 Nigeria Secondary Antibodies Sales and Growth Rate ( 2014-2019)
        5.4.5 Egypt Secondary Antibodies Sales and Growth Rate ( 2014-2019)
        5.4.6 Algeria Secondary Antibodies Sales and Growth Rate ( 2014-2019)

6 EMEA Secondary Antibodies Manufacturers/Players Profiles and Sales Data
    6.1 Thermo Fisher Scientific (US)
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Secondary Antibodies Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Thermo Fisher Scientific (US) Secondary Antibodies Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 Jackson ImmunoResearch Laboratories (US)
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Secondary Antibodies Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Jackson ImmunoResearch Laboratories (US) Secondary Antibodies Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 BD Biosciences (US)
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Secondary Antibodies Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 BD Biosciences (US) Secondary Antibodies Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 Santa Cruz Biotechnology (US)
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Secondary Antibodies Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Santa Cruz Biotechnology (US) Secondary Antibodies Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 GE Healthcare (US)
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Secondary Antibodies Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 GE Healthcare (US) Secondary Antibodies Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 Sigma-Aldrich (US)
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Secondary Antibodies Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Sigma-Aldrich (US) Secondary Antibodies Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Dako (US)
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Secondary Antibodies Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Dako (US) Secondary Antibodies Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 LI-COR Biosciences (US)
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Secondary Antibodies Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 LI-COR Biosciences (US) Secondary Antibodies Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview
    6.9 SouthernBiotech (US)
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Secondary Antibodies Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 SouthernBiotech (US) Secondary Antibodies Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.9.4 Main Business/Business Overview
    6.10 Vector Laboratories (US)
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Secondary Antibodies Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Vector Laboratories (US) Secondary Antibodies Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.10.4 Main Business/Business Overview
    6.11 Bio-Rad (US)
    6.12 eBioscience (US)
    6.13 Cell Signaling Technology (US)
    6.14 Dianova (Germany)
    6.15 Abcam (UK)
    6.16 EMD Millipore (US)
    6.17 R&D Systems (US)
    6.18 Rockland Immunochemicals (US)
    6.19 Bethyl (US)
    6.20 Kirkegaard & Perry Laboratories (US)
    6.21 BioLegend (US)
    6.22 Abbexa (UK)
    6.23 Biorbyt (UK)
    6.24 Acris Antibodies (Germany)
    6.25 BioLogo (Germany)
    6.26 Sino Biological (China)

7 Secondary Antibodies Manufacturing Cost Analysis
    7.1 Secondary Antibodies Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Secondary Antibodies

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Secondary Antibodies Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Secondary Antibodies Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Secondary Antibodies Market Forecast ( 2019-2025)
    11.1 EMEA Secondary Antibodies Sales, Revenue and Price Forecast ( 2019-2025)
        11.1.1 EMEA Secondary Antibodies Sales and Growth Rate Forecast ( 2019-2025)
        11.1.2 EMEA Secondary Antibodies Revenue and Growth Rate Forecast ( 2019-2025)
        11.1.3 EMEA Secondary Antibodies Price and Trend Forecast ( 2019-2025)
    11.2 EMEA Secondary Antibodies Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.3 Europe Secondary Antibodies Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.4 Middle Eastt Secondary Antibodies Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.5 Africa Secondary Antibodies Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.6 EMEA Secondary Antibodies Sales Forecast by Type ( 2019-2025)
    11.7 EMEA Secondary Antibodies Sales Forecast by Application ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer